Recurrent PAK2 rearrangements in poroma with folliculo‐sebaceous differentiation

Poroma is a benign adnexal neoplasm with differentiation towards the upper portion of the sweat gland apparatus. In 2019, Sekine et al. demonstrated recurrent YAP1::MAML2 and YAP1::NUTM1 fusion in poroma and porocarcinoma. Follicular, sebaceous and/or apocrine differentiation has been reported in rare cases of poroma and whether these tumours constitute a variant of poroma or represent a distinctive tumour is a matter to debate. Herein we describe the clinical, immunophenotypic, and molecular features of 13 cases of poroma with folliculo‐sebaceous differentiation.

[1]  F. Tirode,et al.  Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1‐deficient skin carcinoma , 2023, Histopathology.

[2]  R. Penin,et al.  Poroma: A Retrospective Series of 80 Patients at a Tertiary Care Hospital. , 2022, Actas dermo-sifiliograficas.

[3]  R. Penin,et al.  Poroma: A Retrospective Series of 80 Patients at a Tertiary Care Hospital. , 2022, Actas Dermo-Sifiliográficas.

[4]  M. Battistella,et al.  Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors , 2022, Cancers.

[5]  J. Brognard,et al.  New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases , 2021, International journal of molecular sciences.

[6]  Z. Dong,et al.  CDK12 and PAK2 as novel therapeutic targets for human gastric cancer , 2020, Theranostics.

[7]  K. Tsuta,et al.  Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. , 2019, The Journal of clinical investigation.

[8]  Steven J. M. Jones,et al.  Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma , 2018, npj Precision Oncology.

[9]  D. Pissaloux,et al.  Cutaneous Melanocytoma With CRTC1-TRIM11 Fusion: Report of 5 Cases Resembling Clear Cell Sarcoma , 2017, The American journal of surgical pathology.

[10]  Yungtai Lo,et al.  Holocrine Poroma: A Distinctive Adnexal Tumor , 2017, The American Journal of dermatopathology.

[11]  K. Hoeflich,et al.  p21-Activated Kinase 2 Regulates Endothelial Development and Function through the Bmk1/Erk5 Pathway , 2015, Molecular and Cellular Biology.

[12]  R. Xie,et al.  Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer , 2014, Diagnostic Pathology.

[13]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[14]  E. Manser,et al.  PAK family kinases , 2012, Cellular logistics.

[15]  H. Kutzner,et al.  Sebaceous Differentiation in Poroid Neoplasms: Report of 11 Cases, Including a Case of Metaplastic Carcinoma Associated With Apocrine Poroma (Sarcomatoid Apocrine Porocarcinoma) , 2008, The American Journal of dermatopathology.

[16]  P. H. Mckee,et al.  Eccrine Porocarcinoma (Malignant Eccrine Poroma): A Clinicopathologic Study of 69 Cases , 2001, The American journal of surgical pathology.

[17]  E. Alnemri,et al.  Cleavage and activation of p21-activated protein kinase gamma-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity. , 1998, The Journal of biological chemistry.

[18]  P. Leboit,et al.  Eccrine or apocrine poroma? Six poromas with divergent adnexal differentiation. , 1996, The American Journal of dermatopathology.

[19]  D. Hanau,et al.  [The infundibular adenoma: a follicular poroma with sebaceous and apocrine differentiation (author's transl)]. , 1981, Annales de dermatologie et de venereologie.